Additional file 4 of Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Additional file 4: Supplemental Figure 3. Related to Figure 4.Bioinformatic analysis of association between RUNX1 and ER stress pathway in PDAC at the single-cell level.